On June 30, the Skolkovo Foundation Scientific Advisory Council meeting took place. A decision was made on changing the structure and format of the council’s activities. The event took place in video-conference format. The co-chair of the Scientific...
The company, Kromis , a resident of the biomedical technologies cluster of the Skolkovo Foundation, received a product license from the Ministry of Health of the Russian Federation for the antiviral medication “Avifavir.” Avifavir (the active...
Skolkovo Foundation and Cybernaut Investment Group have signed a cooperation agreement under the auspices of the Russian-Chinese forum “Big opportunities for small- and medium-sized enterprises,” taking place in Beijing on April 21-22. The document...